Conversations with the HPTN
Elizabeth Shambadza (ES) Magada, MA, is a community liaison officer (CLO) for the Parirenyatwa and Spilhaus clinical research sites in Zimbabwe. She has spent more than 19 years working in large and complex HIV treatment, care, and behavior change projects under the University of Zimbabwe in collaboration with the University of California San-Francisco (UZ-UCSF).
Roy (“Trip”) M. Gulick, MD, MPH, is the Rochelle Belfer Professor in Medicine and chief of the Division of Infectious Diseases at Weill Cornell Medicine, and attending physician at the New York Presbyterian Hospital in New York City. He serves as the co-chair of the U.S. Department of Health and Human Services (DHHS) Panel on Clinical Practices for Treatment of HIV Infection and chairman of the National Institutes of Health (NIH) Office of AIDS Research Advisory Committee (OARAC).
Josephine Ayankoya, MPH, is the Community Programs Manager for Bridge HIV, a research unit of the San Francisco Department of Public Health. In this role, she leads the organization's recruitment, education, and engagement efforts for NIH-funded research studies.
Dr. Chirenje is a professor of obstetrics and gynecology at the College of Health Science at the University of Zimbabwe in Harare. His main research interest is HIV prevention clinical trials in women with particular emphasis on microbicides and pre-exposure prophylaxis development and cervical cancer screening/treatment of pre-cancer lesions in low resource settings. He is also principal investigator for a large U.S. National Institutes of Health-funded HIV clinical trials unit (UZ-UCSF) that is executing clinical trials for four networks (ACTG, IMPAACT, MTN, HPTN).